Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.
Metrics to compare | 2784 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship2784PeersSector | |
---|---|---|---|---|
P/E Ratio | 14.2x | 15.8x | −0.7x | |
PEG Ratio | −3.01 | 1.17 | 0.00 | |
Price/Book | 0.8x | 1.2x | 2.6x | |
Price / LTM Sales | 0.1x | 0.4x | 3.4x | |
Upside (Analyst Target) | 2.6% | 1.2% | 35.7% | |
Fair Value Upside | Unlock | 30.5% | 4.1% | Unlock |